Svas Biosana SpA

Svas Biosana SpA FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Svas Biosana SpA (SVS.MI) as of Nov 4, 2026 is -84.04 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -16.87 % — a change of 398.20% (lower).

FCF Conversion

-84.04 %

YoY

398.20%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Svas Biosana SpA is 2025 -84.04 % . FCF Conversion Rate (FCF/EBITDA) of Svas Biosana SpA was 2024 -16.87 % . It decreases by 398.20% lower compared to the previous year.

The Svas Biosana SpA FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-0.37 EUR
Jan 1, 2019
98.07 EUR
Jan 1, 2020
415.56 EUR
Jan 1, 2021
-2.64 EUR
Jan 1, 2022
0.31 EUR
Jan 1, 2023
-29.94 EUR
Jan 1, 2024
-16.87 EUR
Jan 1, 2025
-84.04 EUR
The Svas Biosana SpA FCF Conversion history
YEARFCF ConversionYoY
-84.04 %+398.20%
-16.87 %-43.66%
-29.94 %-9,868.35%
0.31 %-111.60%
-2.64 %-100.64%
415.56 %+323.75%
98.07 %-26,914.49%
-0.37 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Svas Biosana SpA Stock analysis

What does Svas Biosana SpA do? Svas Biosana SpA distributes medical appliances through its four divisions: Farmex manufactures gauze and cotton products, Medical provides suction lines, infusion lines, and custom packs, Svas offers own brand products including specialities, galenic solutions, and disposables, and Harvest supplies electromedical equipment with after-sales technical services. The company is a subsidiary of Svas group and serves healthcare providers and medical facilities. The firm's products are sold to hospitals, clinics, and healthcare institutions requiring medical supplies and equipment. Svas Biosana SpA generates revenue from the sale of its medical appliance products across all four divisions. Farmex's gauze and cotton products are purchased by healthcare institutions for wound care and medical procedures. Medical division's suction and infusion lines are bought by hospitals for patient care and treatment. Svas division's own brand products, including specialities and disposables, are sold to medical facilities seeking branded solutions. Harvest division's electromedical equipment and technical services are contracted by healthcare providers needing advanced medical devices and support. The company's business model focuses on distributing medical appliances through its four specialized divisions, each targeting specific segments of the healthcare market. Farmex serves the basic medical supplies segment with gauze and cotton products. Medical targets acute care settings with suction and infusion lines. Svas division caters to facilities requiring branded medical products and solutions. Harvest division addresses the need for electromedical equipment and technical support services in healthcare environments. All divisions contribute to the company's revenue through direct sales to healthcare institutions and providers. Svas Biosana SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Svas Biosana SpA stock

FCF Conversion Rate (FCF/EBITDA) of Svas Biosana SpA is -84.04 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Svas Biosana SpA changed from -16.87 % to -84.04 %, representing a 398.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Svas Biosana SpA since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Svas Biosana SpA with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Svas Biosana SpA

All Key Metrics — Svas Biosana SpA